Treatments for Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Critical Appraisal and Systematic Review

Clicks: 1
ID: 316877
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #243 of 304 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 304 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Although Stevens–Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are rare, their impact on children is disproportionately severe, with recent US data suggesting a rising incidence of 0.5–6.3 cases per 100,000 children annually. Pediatric SJS/TEN is characterized by substantial mortality, long-term physical and psychological sequelae, and frequent overlap features that complicate diagnosis. Despite this, pediatric-specific evidence is scarce. Ethical constraints preclude randomized controlled trials (RCTs), leaving clinicians without consensus guidelines on systemic therapies. To address this gap, we systematically reviewed real-world treatment approaches and outcomes in pediatric SJS/TEN.
Reference Key
openalex_W7164184828 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yu‐Chieh Chiu, Sheng-Hsiang Ma, Tai‐Li Chen
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag237
URL
https://doi.org/10.1093/bjd/ljag237
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.